tissue-plasminogen activator - Globe Thesis

Keyword [tissue-plasminogen activator] Result: 61 - 80 \| Page: 4 of 8
61.	Mmp-1 And T-pa Treatment Of Rabbit Proliferative Vitreoretinopathy Experimental Research
62.	Left Atrial Appendage Ligation Rabbit Coagulation And Fibrinolysis System And Atrial Natriuretic Peptide In Rats
63.	Genetic Susceptibility To Sepsis Based On The Candidate Gene Strategy
64.	Values Of Biomarkers In The Detection Of Existence And Severity Of Coronary Arterial Atherosclerosis
65.	Preparation Of Heparan Suleate And Dermatan Sulfate And Their Synergism On Antithrombotic Related Bioactivities
66.	The Construction Of Bovine αS1casein-htPA Hybrid Locus Vector And It Confer HtPA Expression In Milk Of Transgenic Mice
67.	Predictors Of Clinical Outcome In Patients With Acute Ischemic Stroke Who Received Tissue Plasminogen Activator Therapy
68.	Clinical Prognostic Analysis Of Intravenous Thrombolysis For Acute Brain Infarction
69.	Clinical Study On Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator
70.	Changes Of The Brain-derived Neurotrophic Factor Lysis Pathway And Synaptic Plasticity In Rats After Chronic Stress And Escitalopram Treatment
71.	Low-Dose Ketamine Combined With Propofol Alleviates Electroconvulsive Shock-Indued Memory Impairment By Modulating TPA-BDNF Pathway In Depressive Rats
72.	Study Of Outcome By Cerebral Infarct Etiology In Patients Receiving Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator (rtPA)
73.	The Early Outcomes Correlated Factors Of Acute Ischemic Stroke Patients With Thrombolysis
74.	Construction Of Human Tissue-Type Plasminogen Activator Prokaryotic Expression Vector And Its Preliminary Expression In Escherichia Coli
75.	The Coagulation And Fibrinolytic Function Changes After Transcatheter Closure Of Atrial Septal Defect: A Randomized, Controlled Clinical Study
76.	The Intervention Of TGF-β1on The Hemorrhagic Transformation Induced By Recombinant Tissue Plasminogen Activator In Ischemic Stroke
77.	Risk Factor For Patients Treated By Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator In Acute Cerebral Infarction
78.	Neuroserpin Expressed In Rat Spinal Cord Continuous Compression Injury Research
79.	Theoretical Discussion And Experimental Research On The Treatment Mechanism Of Tao By Ajianqingying Recipe
80.	The Factors That Affect The Clinical Outcomes Of Acute Ischemic Stroke Patients Treated With Intravenous Recombinant Tissue Plasminogen Activator
<<First <Prev Next> Last>> Jump to